文献速递中医儿科中药与中成药合理使用

中药注射剂治疗新生儿缺氧缺血性脑病的贝叶斯网络荟萃分析

Traditional Chinese medicine for neonatal hypoxic-ischemic encephalopathy: A Bayesian network meta-analysis.
PubMed 文献 · J Ethnopharmacol · 2023-10-12

该贝叶斯网络荟萃分析纳入46项随机对照试验共3448例新生儿缺氧缺血性脑病患者,比较7种中药注射剂联合传统对症治疗与单用传统对症治疗的疗效。结果显示各中药注射剂联合治疗均显著改善治疗表现,其中参麦注射液在临床有效率和原始反射恢复时间上占优,复方麝香注射液在治愈率和NBNA上最优,川芎嗪注射液降低后遗症发生率最佳;安全性证据尚需更多支持。

要点

  • 中药注射剂联合传统对症治疗较单用传统对症治疗可改善新生儿HIE治疗表现。
  • 复方麝香注射液联合治疗在治愈率和NBNA上可能最优。
  • 川芎嗪注射液联合治疗在降低后遗症发生率上可能最优。

核心结论

  • 中药注射剂联合传统对症治疗较单用传统对症治疗可改善新生儿HIE的治疗表现并使患者获益。
  • 综合临床有效率及其他结局,复方麝香注射液联合传统对症治疗对新生儿HIE的改善可能更优。
  • 安全性方面尚需更多证据支持。

研究设计与样本

  • 贝叶斯网络荟萃分析,检索多个数据库自建库至2023年2月9日的文献。
  • 纳入46项随机对照试验,共3448例患者,涉及7种中药注射剂。
  • 采用Cochrane偏倚风险工具评估纳入研究质量,使用STATA 17.0和R 4.2.2软件分析,以SUCRA概率值排序。

主要发现

  • 参麦注射液、复方麝香注射液、川芎嗪注射液、复方丹参注射液、黄芪注射液、银杏叶提取物注射液和葛根素注射液联合传统对症治疗均较单用传统对症治疗显著改善治疗表现。
  • 参麦注射液联合传统对症治疗在临床有效率和原始反射恢复时间上具有明显优势。
  • 复方麝香注射液联合传统对症治疗在治愈率和新生儿行为神经评估(NBNA)上最具优势。
  • 川芎嗪注射液联合传统对症治疗在降低后遗症发生率上表现最佳。
  • 所有文章报告无明显药物不良反应/不良事件(ADRs/ADEs)。

关键数值与推荐

  • 共纳入46项随机对照试验,涉及3448例患者和7种中药注射剂。
  • SUCRA概率值用于排序所考察的治疗。
  • 参麦注射液联合传统对症治疗在临床有效率和原始反射恢复时间上占优。
  • 复方麝香注射液联合传统对症治疗在治愈率和NBNA上最优。
  • 川芎嗪注射液联合传统对症治疗降低后遗症发生率最佳。

临床怎么用

  • 在传统对症治疗基础上,可考虑联合中药注射剂以改善新生儿HIE的治疗表现。
  • 综合临床有效率等结局,复方麝香注射液联合传统对症治疗可能优先考虑。
  • 需关注安全性证据的局限性,临床决策应结合具体患者情况。

局限性

  • 安全性结论尚需更多证据支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Although therapeutic hypothermia is currently considered an effective treatment for neonatal hypoxic-ischemic encephalopathy (HIE), neonatal HIE is a disease requiring multiple therapeutic measures. Related Chinese herbal injections (CHIs) have been carried out in Chinese local hospitals for several years, and the outcomes all seem to show positive results. At the same time, other Traditional Chinese medicine (TCM) methods have also shown vigorous vitality. AIM OF THE STUDY: This study constructed a network meta-analysis (NMA) to investigate the efficacy of CHIs including Shenmai Injection (SMI), Compound musk injection (SXI), Ligustrazine injection (CXI), Compound danshen injection (DSI), Astragalus injection (HQI), Ginkgo biloba extract injection (YXI), and Puerarin injection (GGI) combined with traditional symptomatic treatment (TST) and TST alone in HIE. METHODS: A literature review was conducted in several databases from inception to 9 February 2023. The quality of the included studies was assessed by the Cochrane risk of bias tool. Data were analyzed by STATA 17.0 and R 4.2.2 software. Surface under the cumulative ranking curve (SUCRA) probability values were applied to rank the examined treatments. Bayesian network meta-analysis was designed to access the effectiveness of different CHIs. RESULTS: A total of 46 eligible randomized controlled trials involving 3,448 patients and 7 CHIs were included. The results of the NMA showed that SMI, SXI, CXI, DSI, HQI, YXI, and GGI combined with TST significantly improved treatment performance compared to TST alone. SMI + TST had obvious superiorities in the clinical effective rate and the original reflection recovery time. SXI + TST was the most advantageous in the Cure rate and the Neonatal Behavioral Neurological Assessment (NBNA). CXI + TST was shown to reduce the incidence of sequelae best. All articles reported that there were no obvious adverse drug reactions/adverse drug events (ADRs/ADEs). CONCLUSION: This NMA showed that using CHIs in combination with TST improved treatment performance and could be beneficial for patients with HIE compared to using TST alone. Thereinto, SXI + TST showed a preferable improvement in patients with HIE when unified considering the clinical effective rate and other outcomes. As for safety, more evidence is needed to support this hypothesis.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Zhang C, Guo J, Yin H, et al. Traditional Chinese medicine for neonatal hypoxic-ischemic encephalopathy: A Bayesian network meta-analysis. J Ethnopharmacol. 2023. PMID: 37832809. doi:10.1016/j.jep.2023.117317

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。